Please find our World AIDS Day Statement as we enhance our advocacy towards access to injectable CAB-LA for HIV prevention in our region and beyond!

A Special Edition of the CAB-LA newsletter: You will find the Milestones for CAB-LA Access and Progress Achieved through Community Advocacy- Where are we now and how did we get here? We hope you enjoy reading!

Please see the latest CAB-LA newsletter, which we hope you enjoy reading.You will also find a recap and key status updates on where are we now with CAB-LA.

Please see the latest CAB-LA newsletter, which we hope you find informative.

Please find the latest edition of the CAB-LA newsletter, which we hope you find informative.

Please see the latest CAB-LA newsletter here which we hope you enjoy reading! You will also find our latest infographic which showcases findings from a poll of HIV prevention preferences which was conducted in AFROCAB’s booth within the Global Village at the 24th International AIDS Conference earlier this month.

Please find attached the latest edition of the CAB-LA newsletter here, which we hope you find informative.

Please see our CAB-LA newsletters here, and here which include a summary of key updates and news surrounding long-acting cabotegravir (CAB-LA), including information presented at the recent 24th International AIDS Conference in Montreal and the next steps which follow the announcement of the voluntary licensing agreement between ViiV Healthcare and the Medicines Patent Pool for long-acting […]

The statement can be found here

Afrocab shared a letter from about 200 advocates that shares our concern regarding the slow pace at which the important drug Cabotegravir – Long-Acting (CAB-LA) is made accessible to all who need it.We welcome Dr Nkengasong’s leadership in engaging key stakeholders, including the originator manufacturer ViiV Healthcare, policy-makers, such as WHO and national governments, and […]